Chemical formula: C₂₃H₃₂N₆O₄S Molecular mass: 488.603 g/mol PubChem compound: 110634
Vardenafil is a potent and selective inhibitor of the cGMP specific phosphodiesterase type 5 (PDE5), the most prominent PDE in the human corpus cavernosum. Vardenafil is an oral therapy for the improvement of erectile function in men with erectile dysfunction. In the natural setting, i.e. with sexual stimulation it restores impaired erectile function by increasing blood flow to the penis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G04BE09 | Vardenafil | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIVANZA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Vardenafil is an active ingredient of these brands:
Australia (AU)
Austria (AT)
Brazil (BR)
Cyprus (CY)
Estonia (EE)Israel (IL)
Italy (IT)
Lithuania (LT)Mexico (MX)
Netherlands (NL)
New Zealand (NZ)
Poland (PL)Singapore (SG)
South Africa (ZA)
Spain (ES)Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
